The Centers for Medicare & Medicaid Services (CMS) Innovation Center has announced a new voluntary Enhanced Oncology Model (EOM). Under the EOM, participating oncology practices will take on financial and performance accountability for episodes of care surrounding systemic chemotherapy administration to Medicare patients with common cancer types.
The EOM is a five-year voluntary model, running from July 1, 2023, through June 2028. Model participants will include oncology practices that treat Medicare beneficiaries undergoing chemotherapy for breast cancer, chronic leukemia, lung cancer, lymphoma, multiple myeloma, prostate cancer, and small intestine/colorectal cancer.
Additional information, including a schedule of webinars covering various aspects of the model, is available on the CMS EOM website.